by admin4620 | Jul 13, 2020 | News
Download the joint position paper The EU must ensure access to affordable and quality medicines in Europe whilst guaranteeing everyone’s right to a healthy and sustainable environment. Human medicine is not an ordinary commodity – public interest and public health...
by admin4620 | Jun 25, 2020 | News
The Access to COVID-19 Tools Accelerator (ACT-A) was launched by the World Health Organization (WHO), governments and global health actors as an ‘unprecedented and inclusive partnership’ to address some of the challenges linked with the management of the COVID-19...
by admin4620 | May 4, 2020 | News
Download the full statement Concrete actions needed for global pledges to result in access for all 4th May 2020 We welcome the efforts of the global health actors and other stakeholders to rally financial support to the research and development (R&D),...
by admin4620 | Apr 29, 2020 | News
The European Alliance for Respondible R&D and Affordable Medicines joined the international global health community to call on governments, agencies, manufacturers, donors and development partners to commit to global principles for access, innovation and access....
by admin4620 | Mar 24, 2020 | News
On 25th March 2020, 62 organisations including patients, consumers, healthcare professionals, trade unions and public interest organisations published a letter to express our views on the importance of the role of public support to research and development during the...
by admin4620 | Dec 13, 2019 | News
Under the future Partnership between the European Commission and the healthcare sector industries, a considerable amount of public funds will be allocated to health research and innovation projects. 43 organisations including patients, consumers, doctors, payers, HTAs...
